CoChat

Translating Molecular Advances in Fragile X Syndrome Into Therapy: A Review

Hagerman, Randi J., Des-Portes, Vincent, Gasparini, Fabrizio, Jacquemont, Sébastien, Gomez-Mancilla, Baltazar · 2014 · The Journal of Clinical Psychiatry
Cited by 52

The DOI matches its Crossref record.

Abstract

Article Abstract Fragile X syndrome is an inherited disease with cognitive, behavioral, and neurologic manifestations, resulting from a single genetic mutation. A variety of treatments that target individual symptoms of fragile X syndrome are currently utilized with limited efficacy. Research in animal models has resulted in the development of potential novel pharmacologic treatments that target the underlying molecular defect in fragile X syndrome, rather than the resultant symptoms. This review describes recent advances in our understanding of the molecular basis of fragile X syndrome and summarizes the ongoing clinical research programs. J Clin Psychiatry 2014;75(4):e294-e307 © Copyright 2014 Physicians Postgraduate Press, Inc. Submitted: August 5, 2013; accepted January 16, 2014 (doi:10.4088/JCP.13r08714). Corresponding author: Baltazar Gomez-Mancilla, MD, PhD, Department of Neuroscience, Translational Medicine, Novartis Institutes of Biomedical Research, WSJ.210.25.5, CH-4056 Basel, Switzerland (baltazar.gomezmancilla@novartis.com).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4088/jcp.13r08714

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 52

Metadata

Authors
Hagerman, R. J., Des-Portes, V., Gasparini, F., Jacquemont, S., & Gomez-Mancilla, B.
Venue
The Journal of Clinical Psychiatry
Published
2014-04-15
Volume
75
Issue
04
Pages
e294-e307
ISSN
0160-6689 (ISSN-L)
OpenAlex
W1995251705
Cited by
52
References
0
FWCI
6.74
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Translating Molecular Advances in Fragile X Syndrome Into Therapy: A Review. https://app.cochat.ai/papers/10.4088/jcp.13r08714
The paper
Hagerman, R. J., Des-Portes, V., Gasparini, F., Jacquemont, S., & Gomez-Mancilla, B. (2014). Translating Molecular Advances in Fragile X Syndrome Into Therapy: A Review. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.13r08714

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.